About
CureSee is the world's most advanced AI-based vision therapy platform, as featured on Shark Tank India. Built for eye care professionals and their patients, it provides scientifically backed treatment for conditions including Amblyopia (Lazy Eye), Computer Vision Syndrome, post-Scleral Lens adaptation, and post-Refractive Surgery recovery. The platform harnesses cutting-edge technologies including Gabor Patch exercises, Random Dot Stereogram (RDS), Dichoptic Principle, Anti-Suppression Technology, and Crowding Phenomenon to deliver measurable improvements in visual acuity, stereopsis (depth perception), and vergence values. A published clinical study by Maples Scientific Publishers involving 68 amblyopic patients over six months confirmed statistically significant improvements across all key visual metrics. Built as a SaaS solution, CureSee is designed to be doctor-friendly, requiring minimal technical knowledge to deploy and manage. It is available both online and offline, ensuring therapy continuity regardless of internet connectivity — a key differentiator for patients in underserved areas. With over 9,000 happy patients, 350+ associated doctors, presence in 80+ cities, and 5 industry awards, CureSee is trusted by leading eyecare hospitals and clinics worldwide. It is the go-to platform for clinicians seeking a certified, AI-driven approach to modern vision therapy.
Key Features
- AI-Powered Gabor Patch Therapy: Uses clinically proven Gabor Patch exercises driven by artificial intelligence to effectively treat Amblyopia and improve visual acuity from the comfort of home.
- Online & Offline Availability: CureSee operates both with and without internet connectivity, ensuring uninterrupted vision therapy for patients regardless of location or infrastructure.
- Multi-Condition Treatment Coverage: Addresses a range of eye conditions including Amblyopia, Computer Vision Syndrome, post-Scleral Lens adaptation, and post-Refractive Surgery recovery.
- Clinically Validated Outcomes: A published peer-reviewed study across 68 patients over 6 months demonstrated significant improvements in visual acuity, stereopsis, and vergence values.
- Doctor-Friendly SaaS Platform: Designed for ease of use by eye care professionals with minimal technical overhead, enabling seamless integration of vision therapy into any clinical practice.
Use Cases
- Eye care clinics using CureSee to treat pediatric and adult patients with Amblyopia through structured, AI-guided therapy sessions.
- Optometrists prescribing CureSee for patients suffering from Computer Vision Syndrome caused by prolonged digital screen exposure.
- Post-operative recovery programs integrating CureSee for patients who have undergone Refractive Surgeries or are adapting to Scleral Lenses.
- Patients in remote or low-connectivity regions using CureSee's offline mode to maintain uninterrupted vision therapy at home.
- Eyecare hospitals adopting CureSee as a certified, scientifically proven vision therapy platform to improve patient outcomes and differentiate their services.
Pros
- Clinically Proven Efficacy: Backed by a published open-access study showing measurable, statistically significant improvements in visual acuity and stereopsis in amblyopic patients.
- Works Offline: Unlike most SaaS tools, CureSee is accessible without internet, making it ideal for patients in remote or low-connectivity areas.
- Widely Adopted by Professionals: Trusted by 350+ doctors across 80+ cities and leading eyecare hospitals, demonstrating strong clinical credibility and real-world effectiveness.
- Award-Winning & Shark Tank Recognized: Recognition on Shark Tank India and 5 industry awards highlight the platform's innovation and validated commercial value.
Cons
- Highly Specialized Use Case: CureSee is exclusively focused on vision therapy, limiting its applicability to eye care professionals and specific patient populations.
- Opaque Pricing: Pricing details are not transparently listed on the website, which may create friction for new clinics evaluating adoption.
- Best Under Professional Supervision: Optimal results are achieved under expert clinical supervision, which may limit fully independent home-based use for some patients.
Frequently Asked Questions
What eye conditions does CureSee treat?
CureSee is designed to treat Amblyopia (Lazy Eye), Computer Vision Syndrome, and to support recovery after Scleral/Mini Scleral Lens use and Refractive Surgeries.
Does CureSee work without an internet connection?
Yes. CureSee is available both online and offline, ensuring patients can continue their vision therapy sessions even without internet access.
Is CureSee clinically proven?
Yes. A published open-access clinical study involving 68 amblyopic patients over 6 months showed significant improvements in visual acuity (0.60 LogMar), stereopsis, and vergence values using CureSee.
Who is CureSee designed for?
CureSee is built for eye care professionals — optometrists and ophthalmologists — as well as their patients. It offers a user-friendly interface for doctors to administer, monitor, and manage vision therapy programs.
What technology powers CureSee?
CureSee leverages Artificial Intelligence, Gabor Patches, Random Dot Stereogram (RDS), Dichoptic Principle, Crowding Phenomenon, and Anti-Suppression Technology to deliver effective, evidence-based vision therapy.
